Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Cash & Current Investments (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Cash & Current Investments data on record, last reported at $210.8 million in Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 21.59% to $210.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $210.8 million, a 21.59% increase, with the full-year FY2025 number at $210.8 million, up 21.59% from a year prior.
  • Cash & Current Investments reached $210.8 million in Q4 2025 per NBP's latest filing, down from $228.3 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for NBP hit a ceiling of $118.4 billion in Q4 2021 and a floor of $165.6 million in Q2 2025.
  • A 5-year average of $9.4 billion and a median of $317.3 million in 2023 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 16273.69% in 2021, then crashed 99.61% in 2022.
  • Tracing NBP's Cash & Current Investments over 5 years: stood at $118.4 billion in 2021, then tumbled by 99.61% to $465.5 million in 2022, then crashed by 31.84% to $317.3 million in 2023, then tumbled by 45.35% to $173.4 million in 2024, then grew by 21.59% to $210.8 million in 2025.
  • Business Quant data shows Cash & Current Investments for NBP at $210.8 million in Q4 2025, $228.3 million in Q3 2025, and $165.6 million in Q2 2025.